Many of our fellows hold faculty positions with colleges of veterinary medicine and colleges of pharmacy where they are instrumental in instructing both veterinary and pharmacy students about the medications used in animals The role of the veterinary pharmacist is varied with many clinical and administrative duties including product selection and procurement. Our membership is international with the U.S., Canada, the Netherlands, Denmark, Australia and New Zealand represented. He joined as CFO in September following 22 years at Johnson & Johnson, where he worked his way up from the marketing and business development finance divisions of Janssen Pharmaceuticals to high-ranking spots in J&J’s corporate finance division, including his final appointment as VP of investor relations.The Society of Veterinary Hospital Pharmacists is an organization comprised of pharmacists working exclusively in the veterinary field, primarily at veterinary teaching hospitals in colleges of veterinary medicine. In addition to breaking ground on new research and development facilities, scooping up a handful of tuck-in acquisitions and making plans to separate out its diabetes segment into a standalone $1 billion business, BD has further grown its finance team.ĭeMartino’s superior at the company, DelOrefice, is relatively new to BD as well. Spurred along by its growth-centric BD2025 plan, the medtech giant has been on something of a growth spurt this year. RELATED: BD finds new global finance chief in 20-year Johnson & Johnson vet
And, since 2017, she’s been a founding board member of the CSNK2A1 Foundation, which is dedicated to finding a cure for Okur-Chung neurodevelopmental syndrome. Outside of the office, DeMartino is also a leader at leadership development company Advancing Women Executives. Between 20, she held a series of roles at Johnson & Johnson-which acquired Omrix in late 2008-culminating in her appointment as director of worldwide communications. Prior to that, she held leadership roles in the investor relations departments of communications agencies GCI Health and the Ruth Group, as well as Omrix Biopharmaceuticals and Macrocure. Most recently, she was vice president of investor relations at Medtronic, a two-year stint that followed additional placements at the company as VP of communications first for its diabetes group and then for all of Medtronic. Indeed, DeMartino brings with her nearly two decades of experience in investor relations and corporate communications for medtech and biopharma companies.
0 kommentar(er)
